BIOLASE (BIOL) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free BIOL Stock Alerts $0.15 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media BIOLASE Short Interest DataCurrent Short Volume592,700 sharesPrevious Short Volume2,290,000 sharesChange Vs. Previous Month-74.12%Dollar Volume Sold Short$80,607.20Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares32,520,000 sharesFloat Size31,210,000 sharesShort Percent of Float1.90%Today's Trading Volume612,965 sharesAverage Trading Volume4,498,681 sharesToday's Volume Vs. Average14% Short Selling BIOLASE ? Sign up to receive the latest short interest report for BIOLASE and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIOL Short Interest Over TimeBIOL Days to Cover Over TimeBIOL Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). BIOLASE Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024592,700 shares $80,607.20 -74.1%1.9%0.1 $0.14 3/31/20242,290,000 shares $434,642.00 +692.7%7.5%0.4 $0.19 3/15/2024288,900 shares $40,128.21 +17.6%0.9%0.1 $0.14 2/29/2024245,600 shares $33,892.80 -63.8%0.9%0.1 $0.14 2/15/2024678,600 shares $98,600.58 +602.5%3.1%0.5 $0.15 1/31/202496,600 shares $72,073.26 +375.9%3.0%0.3 $0.75 Get the Latest News and Ratings for BIOL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. 1/15/202420,300 shares $21,112.00 -57.4%0.6%0.1 $1.04 12/31/202347,600 shares $53,407.20 -5.2%1.5%0.2 $1.12 12/15/202350,200 shares $57,228.00 +126.1%1.6%0.2 $1.14 11/30/202322,200 shares $24,198.00 -77.9%1.1%0.1 $1.09 11/15/2023100,500 shares $127,635.00 +1,068.6%5.1%0.3 $1.27 10/31/20238,600 shares $14,448.00 -70.1%1.0%0 $1.68 10/15/202328,800 shares $48,960.00 -74.5%3.2%0.1 $1.70 9/30/2023113,000 shares $210,180.00 -59.0%12.1%0.4 $1.86 9/15/2023275,700 shares $526,587.00 +70.6%29.6%0.8 $1.91 8/31/2023161,600 shares $706,192.00 +4.9%16.2%0.7 $4.37 8/15/2023154,100 shares $947,715.00 -61.4%15.4%0.7 $6.15 7/31/2023399,400 shares $2.43 million -87.2%40.2%2.1 $6.09 7/15/20233,110,000 shares $270,259.00 -44.4%3.8%0.4 $0.09 6/30/20235,590,000 shares $395,213.00 +589.1%6.9%0.7 $0.07 6/15/2023811,200 shares $64,084.80 -61.2%1.1%0.2 $0.08 5/31/20232,090,000 shares $170,335.00 +145.4%8.0%0.6 $0.08 5/15/2023851,600 shares $183,008.84 +4.4%3.7%0.5 $0.21 4/30/2023815,700 shares $203,925.00 +219.5%4.1%0.8 $0.25 4/15/2023255,300 shares $61,833.66 +140.9%1.3%0.3 $0.24 3/31/2023106,000 shares $29,807.20 +127.0%0.5%0.2 $0.28 3/15/202346,700 shares $18,213.00 -59.2%0.2%0.1 $0.39 2/28/2023114,500 shares $58,395.00 -42.4%0.6%0.2 $0.51 2/15/2023198,900 shares $101,399.22 -29.1%1.0%0.3 $0.51 1/31/2023280,400 shares $152,313.28 -31.9%1.4%0.5 $0.54 1/15/2023411,800 shares $175,591.52 -36.7%12.8%0.9 $0.43 12/30/2022650,300 shares $422,695.00 -7.1%9.3%2.7 $0.65 12/15/2022700,100 shares $467,316.75 +108.5%10.0%5.1 $0.67 11/30/2022335,800 shares $324,382.80 +144.2%4.8%3 $0.97 11/15/2022137,500 shares $247,500.00 +8.4%2.0%1.8 $1.80 10/31/2022126,900 shares $248,724.00 -2.0%1.9%3.7 $1.96 10/15/2022129,500 shares $268,065.00 +5.0%1.9%3.9 $2.07 9/30/2022123,300 shares $299,619.00 +5.7%1.8%3.7 $2.43 9/15/2022116,700 shares $378,108.00 +6.4%1.7%3.2 $3.24 8/31/2022109,700 shares $424,539.00 -23.9%1.6%3.1 $3.87“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). BIOL Short Interest - Frequently Asked Questions What is BIOLASE's current short interest? Short interest is the volume of BIOLASE shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 592,700 shares of BIOL short. 1.90% of BIOLASE's shares are currently sold short. Learn More on BIOLASE's current short interest. What is a good short interest percentage for BIOLASE? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.90% of BIOLASE's floating shares are currently sold short. Is BIOLASE's short interest increasing or decreasing? BIOLASE saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 592,700 shares, a decrease of 74.1% from the previous total of 2,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BIOLASE's float size? BIOLASE currently has issued a total of 32,520,000 shares. Some of BIOLASE's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BIOLASE currently has a public float of 31,210,000 shares. How does BIOLASE's short interest compare to its competitors? 1.90% of BIOLASE's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to BIOLASE: Sonendo, Inc. (0.68%), Leafly Holdings, Inc. (3.99%), GT Biopharma, Inc. (0.27%), Oragenics, Inc. (2.07%), Shineco, Inc. (0.13%), Bright Minds Biosciences Inc. (2.76%), Synaptogenix, Inc. (3.21%), Alzamend Neuro, Inc. (0.30%), Acutus Medical, Inc. (2.92%), Palisade Bio, Inc. (4.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short BIOLASE stock? Short selling BIOL is an investing strategy that aims to generate trading profit from BIOLASE as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BIOLASE? A short squeeze for BIOLASE occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOL, which in turn drives the price of the stock up even further. How often is BIOLASE's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SONX Short Interest Data LFLY Short Interest Data GTBP Short Interest Data OGEN Short Interest Data SISI Short Interest Data DRUG Short Interest Data SNPX Short Interest Data ALZN Short Interest Data AFIB Short Interest Data PALI Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIOL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings